5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.05%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.86%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-35.47%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-35.47%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-39.09%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-41.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-41.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
3.54%
Share change of 3.54% while STERV.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.54%
Diluted share change of 3.54% while STERV.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-15.66%
Negative OCF growth while STERV.HE is at 273.39%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-54.73%
Negative FCF growth while STERV.HE is at 34200.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-25.54%
Negative 10Y revenue/share CAGR while STERV.HE stands at 17.68%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-7.94%
Negative 5Y CAGR while STERV.HE stands at 1.12%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
20.17%
3Y revenue/share CAGR above 1.5x STERV.HE's 3.25%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
240.15%
10Y OCF/share CAGR above 1.5x STERV.HE's 89.21%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-68.02%
Negative 5Y OCF/share CAGR while STERV.HE is at 70.85%. Joel Greenblatt would question the firm’s operational model or cost structure.
247.30%
3Y OCF/share CAGR above 1.5x STERV.HE's 5.23%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
134.89%
Net income/share CAGR 1.25-1.5x STERV.HE's 116.04%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
105.96%
Below 50% of STERV.HE's 5800.00%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
66.67%
Positive short-term CAGR while STERV.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
46.50%
5Y equity/share CAGR 1.25-1.5x STERV.HE's 31.95%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
36.39%
3Y equity/share CAGR above 1.5x STERV.HE's 22.36%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
233.14%
Stable or rising mid-term dividends while STERV.HE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
81.82%
Our short-term dividend growth is positive while STERV.HE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-3.07%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
1.73%
We show growth while STERV.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.96%
Negative asset growth while STERV.HE invests at 8.33%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.70%
We have a declining book value while STERV.HE shows 2.85%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
18.05%
Debt growth far above STERV.HE's 11.54%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
9.57%
We expand SG&A while STERV.HE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.